Xencor Inc., of Monrovia, Calif., signed four commercial license agreements with Selexis SA, of Geneva, extending the firms' previous agreement through which Selexis is providing Xencor with access to its Suretechnology platform, as well as cell line development-related services that include personnel, laboratory equipment and laboratory space.